The GSK Medicines Research
Unit is currently involved in a
clinical trial relating to chronic
Hepatitis C virus.
http://www.biotron.com.au/ftp/BIT225-003.pdf
Dr Michelle Miller, BSc, MSc, PhD
Managing Director
Dr Miller has over 20 years in the bioscience industry, with extensive experience in commercializing bioscience research. She completed her PhD in the Faculty of Medicine at Sydney University investigating molecular models of cancer development. Her experience includes a number of years at Johnson and Johnson developing anti-HIV gene therapeutics through preclinical research to clinical trials. Her experience in early-stage start-ups includes time spent as Investment Manager with a specialist bioscience venture capital fund.
She was appointed as Managing Director on 21 June 2002.
- Forums
- ASX - By Stock
- BIT
- glaxosmithkline has interest in biotron ? hmm
glaxosmithkline has interest in biotron ? hmm
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.85M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.1¢ | $27.02K | 1.223M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 131000 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 1295289 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 131000 | 0.022 |
1 | 386499 | 0.021 |
8 | 599273 | 0.020 |
10 | 2914214 | 0.019 |
10 | 1719636 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 1295289 | 4 |
0.024 | 112849 | 1 |
0.025 | 150000 | 1 |
0.027 | 169508 | 3 |
0.029 | 316026 | 1 |
Last trade - 14.33pm 16/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online